Nationa

No data on police excesses during lockdown: MHA

Union Minister of State for Home G. Kishan Reddy. File   | Photo Credit: C.V. Subrahmanyam

The Ministry of Home Affairs (MHA) on Wednesday informed the Rajya Sabha that data on police excesses during COVID-19 lockdown was not maintained centrally. As on September 10, a total of about 40 lakh persons have been kept under surveillance in the wake of the pandemic, it stated.

More than 30 vaccine candidates have been supported and they were in different stages of development, three candidates were in advanced stage of Phase I/II/III trials and more than four candidates in advanced pre-clinical development stage, Minister of State for Home G. Kishan Reddy said in a written reply.

Mr. Reddy said that police and public order were State subjects as per 7th schedule of the Constitution. “Hence, the actions are taken by the respective State Governments. Data pertaining to complaints and cases registered/First Information Report (FIR) regarding harassment/injury/death of individuals in enforcing the COVID-19 lockdown across the country is not maintained centrally,” he stated.

Kharge’s query

Mr. Reddy was responding to a question by the Congress’s Mallikarjun Kharge on instances of excessive police measures leading to harassment/injury/death of individuals in enforcing the lockdown across the country.

The lockdown was first imposed on March 24 and was extended subsequently till June. From June onward phase-wise opening of various sectors were allowed.

Responding to a separate question, MoS Home Nityanand Rai said there were 1,697 laboratories conducting COVID-19 testing and about 1 million samples were being tested a day. As on September 10, a total of 5.4 crore samples have been tested.

“Central Government has been keeping a close watch on the situation since the first case of COVID-19 was reported in China. Soon after the outbreak of novel coronavirus on 7th January, 2020, several measures like progressive tightening of international travel, issuing advisories for members of the public, setting up quarantine facilities etc. were taken by the Central Government to contain the spread of COVID-19,” he said.

Recommended for you
  1. Comments will be moderated by The Hindu editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.

Printable version | Sep 16, 2020 3:16:30 PM | https://www.thehindu.com/news/national/no-data-on-police-excesses-during-lockdown-mha/article32619432.ece

Next Story

No data on police excesses during lockdown: MHA

DCGI allows Oxford to resume trial of Covid-19 vaccine - DCGI ने ऑक्सफोर्ड के कोविड-19 टीके का परीक्षण दोबारा शुरू करने की अनुमति दी | India News in Hindi

DCGI ने ऑक्सफोर्ड के कोविड-19 टीके का परीक्षण दोबारा शुरू करने की अनुमति दी

डीसीजीआई ने दूसरे और तीसरे चरण के परीक्षण के लिए किसी भी उम्मीदवार को चुनने को रोकने वाले अपने पहले के आदेश को रद्द कर दिया

DCGI ने ऑक्सफोर्ड के कोविड-19 टीके का परीक्षण दोबारा शुरू करने की अनुमति दी

प्रतीकात्मक फोटो.

नई दिल्ली:

भारतीय औषधि महानियंत्रक (डीसीजीआई) डॉ.वीजी सोमानी ने मंगलवार को सीरम इंस्टीट्यूट ऑफ इंडिया (एसआईआई) को ऑक्सफोर्ड के कोविड-19 टीके का उम्मीदवारों पर क्लीनिकल ट्रायल (चिकित्सकीय परीक्षण) फिर से शुरू करने की अनुमति दे दी. डीसीजीआई ने दूसरे और तीसरे चरण के परीक्षण के लिए किसी भी उम्मीदवर को चुनने को रोकने वाले अपने पहले के आदेश को रद्द कर दिया.

यह भी पढ़ें

हालांकि डीसीजीआई ने इसके लिए जांच के दौरान अतिरिक्त ध्यान देने समेत अन्य कई शर्ते रखी हैं. एसआईआई से डीजीसीआई ने विपरित परिस्थतियों से निपटने में नियम के अनुसार तय इलाज की भी जानकारी जमा करने को कहा है.

इससे पहले 11 सितंबर को डीसीजीआई ने सीरम इंस्टीट्यूट ऑफ इंडिया को निर्देश दिया था कि कोविड-19 के संभावित टीके के चिकित्सकीय परीक्षण पर रोक लगाई जाए क्योंकि दिग्गज दवा कंपनी एस्ट्राजेनिका ने अध्ययन में शामिल हुए एक व्यक्ति के ''तबीयत खराब'' होने के बाद अन्य देशों में परीक्षण रोक दिया था.



(हेडलाइन के अलावा, इस खबर को एनडीटीवी टीम ने संपादित नहीं किया है, यह सिंडीकेट फीड से सीधे प्रकाशित की गई है।)

Listen to the latest songs, only on JioSaavn.com

अन्य खबरें